GO:0071636 positive regulation of transforming growth factor beta production: Signaling Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0071636 describes any process that activates or increases the frequency, rate, or extent of transforming growth factor-beta (TGF-beta) production.
• TGF-beta production is controlled at transcriptional, post-transcriptional, and secretory levels, and is influenced by steroid-thyroid hormone superfamily members.
• Key regulators include the retinoblastoma susceptibility gene product (RB1), which modulates TGF-beta 1 gene expression.
• TGF-beta production is induced by diverse stimuli such as non-invasive facial rejuvenation modalities and inflammatory mediators.
• Dysregulated TGF-beta production contributes to sepsis survival, fibrosis, osteoarthritis, and cancer progression [1,5].
• CRISPR-based models (knockout, point mutation, knock-in, overexpression) enable causal dissection of genes that regulate TGF-beta production.
Description
Transforming growth factor-beta (TGF-beta) is a pleiotropic cytokine that controls cell proliferation, differentiation, immune responses, and extracellular matrix remodeling [1,4]. The Gene Ontology term GO:0071636, positive regulation of transforming growth factor beta production, captures the biological processes that increase the synthesis or secretion of TGF-beta. This term is critical for understanding how cells amplify TGF-beta signals during development, tissue repair, and disease [4,7]. Researchers study GO:0071636 to identify upstream regulators, feedback loops, and therapeutic targets in fibrosis, cancer, and inflammatory conditions [1,5]. The process is not a single molecular event but a network of transcriptional, post-transcriptional, and secretory mechanisms that converge on TGF-beta abundance [4,8].
positive regulation of transforming growth factor beta production At A Glance
| GO ID | GO:0071636 |
|---|---|
| GO term | positive regulation of transforming growth factor beta production |
| Ontology | biological_process |
| Synonym | positive regulation of TGF-beta production; positive regulation of TGFbeta production; positive regulation of TGF-B production; positive regulation of TGFB production; positive regulation of transforming growth factor-beta secretion |
| Major function | Increases the frequency, rate, or extent of TGF-beta production |
| Related processes | TGF-beta signaling, cytokine secretion, extracellular matrix remodeling, immune regulation |
| Cellular context | Macrophages, fibroblasts, epithelial cells, osteoarthritic synovium, megakaryocytes |
| Disease relevance | Sepsis, fibrosis, osteoarthritis, cancer, inflammation |
What Is GO:0071636?
GO:0071636 is defined as any process that activates or increases the frequency, rate, or extent of production of transforming growth factor-beta. It encompasses positive regulation of TGF-beta secretion, synthesis, and release, and is synonymous with positive regulation of TGF-beta production, TGFbeta production, TGF-B production, and TGFB production.
Why Is positive regulation of transforming growth factor beta production Important in Cell Biology?
GO:0071636 is important because TGF-beta is a master regulator of cell growth, differentiation, and immune homeostasis, and its overproduction drives pathological fibrosis, cancer progression, and chronic inflammation [1,4,5]. Understanding positive regulation of TGF-beta production provides mechanistic insight into how tumors evade immune surveillance and how tissues respond to injury [1,7]. It also informs therapeutic strategies targeting TGF-beta signaling in sepsis, osteoarthritis, and fibrotic diseases [1,5].
• TGF-beta overproduction is linked to poor survival in sepsis due to uncoupling of glycolysis and inflammation in macrophages.
• Positive regulation of TGF-beta production controls cyclooxygenase-2 expression in fibroblasts, impacting inflammation.
• TGF-beta stimulates nerve growth factor production in osteoarthritic synovium, contributing to pain.
• TGF-beta regulates metalloproteinase production in cervical epithelial cells, affecting tissue remodeling.
• Non-invasive facial rejuvenation modalities induce TGF-beta expression, linking the process to skin remodeling.
• The retinoblastoma susceptibility gene product regulates TGF-beta 1 gene expression, connecting cell cycle control to TGF-beta production.
• Steroid-thyroid hormone superfamily members regulate the TGF-beta system, linking endocrine signals to TGF-beta production.
• TGF-beta production is essential for megakaryocytopoiesis regulation.
• Dysregulated TGF-beta production contributes to cancer progression and metastasis.
• Targeting positive regulators of TGF-beta production may offer therapeutic avenues in fibrosis and inflammation [1,5].
What Happens During positive regulation of transforming growth factor beta production?
Transcriptional Activation of TGFB1
In simple terms: The cell increases the reading of the TGF-beta gene to make more mRNA.
Positive regulation of TGF-beta production often begins with transcriptional activation of the TGFB1 gene. The retinoblastoma susceptibility gene product (RB1) regulates TGF-beta 1 gene expression, linking cell cycle control to TGF-beta production. Additionally, members of the steroid-thyroid hormone superfamily can modulate TGF-beta system components at the transcriptional level.
Post-transcriptional and Secretory Control
In simple terms: After mRNA is made, the cell controls how much protein is produced and released.
Beyond transcription, TGF-beta production is regulated post-transcriptionally and at secretion. TGF-beta is synthesized as a latent complex and requires activation for release. Positive regulation can increase the frequency or rate of secretion, as seen in macrophages where TGF-beta uncouples glycolysis and inflammation.
Stimulus-Induced Upregulation
In simple terms: External signals like injury or inflammation can boost TGF-beta production.
Various stimuli increase TGF-beta production. Non-invasive facial rejuvenation modalities induce TGF-beta expression in skin. In osteoarthritic synovium, TGF-beta stimulates nerve growth factor production, indicating a positive feedback loop. In fibroblasts, TGF-beta regulates cyclooxygenase-2 expression, which may further influence TGF-beta production.
Integration with Cell Cycle and Differentiation
In simple terms: TGF-beta production is tied to cell growth and specialization.
Positive regulation of TGF-beta production intersects with cell cycle and differentiation. RB1 regulates TGF-beta 1 gene expression, and TGF-beta itself controls megakaryocytopoiesis [3,8]. In cervical epithelial cells, TGF-beta 1 regulates metalloproteinase production, affecting tissue remodeling.
Key Genes Involved in GO:0071636 positive regulation of transforming growth factor beta production
The following genes and proteins are experimentally implicated in the positive regulation of TGF-beta production.
| Gene | Major Role | Research Relevance |
|---|---|---|
| TGFB1 | Encodes TGF-beta 1, the principal isoform | Central to production regulation; target for KO and overexpression [1,4] |
| RB1 | Regulates TGF-beta 1 gene expression | Links cell cycle to TGF-beta production |
| PTGS2 | Cyclooxygenase-2, regulated by TGF-beta | Feedback in inflammation and fibroblast biology |
| NGF | Nerve growth factor, induced by TGF-beta | Osteoarthritis pain and synovial biology |
| MMPs | Matrix metalloproteinases, regulated by TGF-beta | Tissue remodeling and cancer invasion |
| Steroid-thyroid hormone receptors | Modulate TGF-beta system | Endocrine regulation of TGF-beta production |
| Macrophage metabolic regulators | Control glycolysis and inflammation | Sepsis survival and immune response |
| Megakaryocyte differentiation factors | Regulate megakaryocytopoiesis | Platelet production and hematopoiesis |
| Skin remodeling factors | Induced by rejuvenation modalities | Dermal TGF-beta expression |
| Inflammatory cytokines | Upstream inducers of TGF-beta | Inflammation-associated fibrosis [1,2] |
| Latent TGF-beta complex proteins | Control secretion and activation | Post-transcriptional regulation |
| Transcription factors (e.g., SP1, AP-1) | Regulate TGFB1 promoter | Transcriptional control [4,8] |
| Smad proteins | Mediate TGF-beta signaling feedback | Feedback regulation of production |
| Hypoxia-inducible factors | Induce TGF-beta under low oxygen | Fibrosis and cancer |
| MicroRNAs | Post-transcriptional repression of TGFB1 | Fine-tuning of production |
| Extracellular matrix proteins | Store latent TGF-beta | Microenvironmental regulation |
| Integrins | Activate latent TGF-beta | Release and bioavailability |
| Proteases (e.g., plasmin) | Cleave latent TGF-beta complex | Activation of secreted TGF-beta |
How Is positive regulation of transforming growth factor beta production Regulated?
Positive regulation of TGF-beta production is controlled by multiple layers. Transcriptionally, RB1 and steroid-thyroid hormone receptors modulate TGFB1 expression [4,8]. Post-transcriptionally, microRNAs and RNA-binding proteins influence TGFB1 mRNA stability and translation. Secretion is regulated by the latent TGF-beta complex and proteases that release active TGF-beta. In macrophages, metabolic cues such as glycolysis uncouple inflammation from TGF-beta production, affecting survival in sepsis. In fibroblasts, TGF-beta itself induces cyclooxygenase-2, which may feed back on production. In osteoarthritic synovium, TGF-beta stimulates nerve growth factor, creating a positive feedback loop.
positive regulation of transforming growth factor beta production and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| TGFB1 | Sepsis, fibrosis, cancer | Knockout and overexpression in macrophages and fibroblasts [1,4] |
| RB1 | Cancer, cell cycle dysregulation | Point mutation and knockout in cancer cell lines |
| PTGS2 | Inflammation, fibrosis | Knockout in fibroblasts |
| NGF | Osteoarthritis pain | Knockdown in synovial cells |
| MMPs | Tissue remodeling, cancer invasion | Knockout in epithelial cells |
Sepsis and Immune Dysregulation
In sepsis, TGF-beta uncouples glycolysis and inflammation in macrophages, and its production is linked to survival outcomes. Positive regulation of TGF-beta production may contribute to immune suppression and metabolic dysfunction during sepsis.
Osteoarthritis and Pain
TGF-beta stimulates nerve growth factor production in osteoarthritic synovium, suggesting that increased TGF-beta production exacerbates pain and joint pathology. Targeting positive regulators of TGF-beta production could be a therapeutic strategy.
Fibrosis and Tissue Remodeling
TGF-beta regulates metalloproteinase production in cervical epithelial cells, and its overproduction is associated with fibrosis and aberrant tissue remodeling. Non-invasive facial rejuvenation modalities induce TGF-beta expression, linking the process to dermal remodeling.
Cancer Progression
The TGF-beta system is regulated by steroid-thyroid hormone superfamily members, and dysregulated production contributes to cancer progression. RB1 regulation of TGF-beta 1 gene expression connects cell cycle control to TGF-beta production in cancer.
From positive regulation of transforming growth factor beta production-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X regulate TGF-beta production? | CRISPR knockout in relevant cell type (e.g., macrophages) |
| Does a specific mutation in RB1 affect TGF-beta 1 expression? | Point mutation knock-in in cancer cells |
| Can we tag endogenous TGF-beta for live tracking? | Knock-in of fluorescent tag at TGFB1 locus |
| Does overexpression of gene Y increase TGF-beta secretion? | Overexpression via lentiviral transduction |
| Which genes regulate TGF-beta production in a genome-wide manner? | CRISPR library screening |
| How does TGF-beta production change in osteoarthritis? | Knockout of NGF in synovial cells |
How to Study the positive regulation of transforming growth factor beta production Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | TGFB1 mRNA levels | Transcriptional regulation |
| ELISA | Secreted TGF-beta protein | Secretion rate |
| Western blot | Intracellular TGF-beta protein | Post-transcriptional regulation |
| CRISPR knockout screening | Genes affecting TGF-beta production | Genome-wide regulator discovery |
| CRISPR activation screening | Genes increasing TGF-beta production | Positive regulator identification |
| Fluorescent reporter knock-in | Real-time TGF-beta production | Live imaging |
| Co-immunoprecipitation | Protein interactions in TGF-beta complex | Latent complex assembly |
Transcriptional Profiling
RNA-seq and qPCR measure TGFB1 mRNA levels after genetic or environmental perturbations. This identifies transcriptional regulators of TGF-beta production [4,8].
Protein Quantification
ELISA and Western blot quantify secreted and intracellular TGF-beta protein. These methods assess post-transcriptional and secretory regulation [1,4].
CRISPR Screening
Genome-wide CRISPR knockout or activation screens identify positive regulators of TGF-beta production. Hits are validated by targeted knockout or overexpression.
Imaging and Reporter Assays
Fluorescent reporters knocked into the TGFB1 locus enable live tracking of production. Imaging in co-culture models reveals cell-type-specific regulation.
How CRISPR Can Be Used to Study GO:0071636 positive regulation of transforming growth factor beta production
Knockout
CRISPR knockout of candidate genes (e.g., RB1, PTGS2) in cell models determines whether they are necessary for TGF-beta production. This causal test is essential for validating screen hits [1,8].
Point Mutation
Point mutations in regulatory regions or coding sequences of genes like RB1 can mimic disease-associated variants and reveal their impact on TGF-beta production.
Knock-in
Knock-in of tags (e.g., FLAG, GFP) at the TGFB1 locus allows tracking of endogenous TGF-beta production and secretion without overexpression artifacts.
Overexpression
Overexpression of candidate positive regulators (e.g., transcription factors) tests sufficiency for increasing TGF-beta production. This complements knockout studies.
How EDITGENE Supports positive regulation of transforming growth factor beta production Research
Researchers studying positive regulation of transforming growth factor beta production-related genes often need to determine whether a candidate gene is causally involved in increasing TGF-beta levels. EDITGENE provides CRISPR-based cell model services to enable such causal experiments.
Contact EDITGENE today to design your custom CRISPR model for positive regulation of transforming growth factor beta production research.
Frequently Asked Questions About positive regulation of transforming growth factor beta production
What is GO:0071636?
GO:0071636 is the Gene Ontology term for positive regulation of transforming growth factor beta production, describing processes that increase TGF-beta synthesis or secretion.
What genes are involved in positive regulation of TGF-beta production?
Key genes include TGFB1, RB1, PTGS2, NGF, and MMPs, among others [1,2,5,6,8].
How is TGF-beta production regulated?
It is regulated transcriptionally (e.g., by RB1), post-transcriptionally, and at secretion via the latent complex and proteases [4,8].
What diseases are linked to increased TGF-beta production?
Sepsis, osteoarthritis, fibrosis, and cancer are associated with dysregulated TGF-beta production [1,4,5,6].
What methods study TGF-beta production?
RNA-seq, ELISA, Western blot, CRISPR screens, and reporter assays are commonly used [1,4].
Can CRISPR knockout help study TGF-beta production?
Yes, knockout of candidate genes can determine necessity for TGF-beta production [1,8].
What is the role of RB1 in TGF-beta production?
RB1 regulates TGF-beta 1 gene expression, linking cell cycle control to TGF-beta production.
How does TGF-beta affect osteoarthritis?
TGF-beta stimulates nerve growth factor production in osteoarthritic synovium, contributing to pain.
What is the relationship between TGF-beta and sepsis?
TGF-beta uncouples glycolysis and inflammation in macrophages and controls survival during sepsis.
How can I model positive regulation of TGF-beta production in the lab?
Use CRISPR knockout, knock-in, overexpression, or library screening in relevant cell types [1,4].
Conclusion
GO:0071636 positive regulation of transforming growth factor beta production is a central process in cytokine biology, with broad implications for immunity, tissue remodeling, and disease. Understanding its genetic and molecular regulators offers opportunities for therapeutic intervention in sepsis, osteoarthritis, fibrosis, and cancer [1,4,5]. CRISPR-based models provide powerful tools to dissect these mechanisms causally.
References
- 1. Gauthier T et al.. 2023. TGF-β uncouples glycolysis and inflammation in macrophages and controls survival during sepsis.. Sci Signal 16(797):eade0385 PMID: 37552767
- 2. Matsumura T et al.. 2009. Regulation of transforming growth factor-beta-dependent cyclooxygenase-2 expression in fibroblasts.. J Biol Chem 284(51):35861-71 PMID: 19837676
- 3. Caen JP et al.. 1999. Regulation of megakaryocytopoiesis.. Haemostasis 29(1):27-40 PMID: 10494032
- 4. Koli K et al.. 1996. Transforming growth factor-beta system and its regulation by members of the steroid-thyroid hormone superfamily.. Adv Cancer Res 70:63-94 PMID: 8902054
- 5. Takano S et al.. 2019. Transforming growth factor-β stimulates nerve growth factor production in osteoarthritic synovium.. BMC Musculoskelet Disord 20(1):204 PMID: 31077183
- 6. Agarwal C et al.. 1994. Transforming growth factor beta 1 regulation of metalloproteinase production in cultured human cervical epithelial cells.. Cancer Res 54(4):943-9 PMID: 8313385
- 7. El-Domyati M et al.. 2015. Expression of transforming growth factor-β after different non-invasive facial rejuvenation modalities.. Int J Dermatol 54(4):396-404 PMID: 25514823
- 8. Kim SJ et al.. 1991. Regulation of transforming growth factor beta 1 gene expression by the product of the retinoblastoma-susceptibility gene.. Proc Natl Acad Sci U S A 88(8):3052-6 PMID: 1901652
